A pretreatment 18F-FDG PET/CT-based nomogram for the differential diagnosis of primary gastric cancer and primary gastric diffuse large B-cell lymphoma

Read full text Summarise with VIRAT
Authors: Ran Wang, Wei J. Wang, Xun Shi, Fei Wu, Xiuqing Xue
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: F-FDG PET/CT) with morphological features derived from the concurrent CT imaging. Methods: F-FDG PET/CT were retrospectively analyzed, including 86 cases of GC and 25 cases of PG-DLBCL. A nomogram was constructed based on imaging features from the CT scan (primary lesion type and involvement of infra-renal lymph nodes) and PET-derived semiquantitative parameters, specifically the tumor-to-liver standardized uptake value ratio (TLR-SUV). The diagnostic performance and clinical utility of the model were evaluated using the area under the curve (AUC), calibration plots, and decision curve analysis (DCA). Results: Primary lesiontype, infra-renal lymph node involvement, and TLR-SUV were identified as independent discriminators between GC and PG-DLBCL. The integrated nomogram model combining CT-based morphological characteristics and PET-derived metabolic metrics achieved an AUC of 0.877 [95% confidence interval (CI): 0.796-0.957] for distinguishing GC from PG-DLBCL, demonstrating robust discrimination and excellent calibration. DCA further confirmed the model's potential to provide valuable clinical decision support across a range of risk thresholds. Conclusions: The nomogram model constructed by integrating concurrent CT morphological features with PET metabolic parameters exhibited high diagnostic efficacy in distinguishing GC from PG-DLBCL, and serves as a promising non-invasive imaging tool.

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Medical Imaging Techniques and Applications Gastric Cancer Management and Outcomes

Publication details

Journal / source
Translational Cancer Research
Volume
15
Issue
3
Pages
166–166
Publication date
1 March 2026
Language
EN